Oral Health-Related Quality of Life among an Australian sample of people who inject drugs
MetadataShow full item record
Objectives - People who inject drugs (PWID) have poor oral health. However, their oral health-related quality of life (OHRQoL) is unknown. Our study was designed to measure the OHRQoL of PWID. Methods - The Oral Health Impact Profile-14 (OHIP-14) was administered to 794 PWID recruited in Australian capital cities as part of the 2013 Illicit Drug Reporting System (IDRS). Three OHIP-14 summary indicators were examined: “Prevalence” (proportion reporting ≥1 item at least “fairly often”), “severity” (mean total OHIP-14 score), and “extent” (number of impacts reported at least “fairly often”). Associations between “prevalence” and “extent” and variables drawn from the health, drug use, and social domains were investigated. Results - All OHIP-14 summary indicators among IDRS participants were significantly higher than in the general Australian population. In multivariate analysis, the “prevalence” indicator was significantly and positively associated with female gender [adjusted odds ratio (AOR) = 1.75, 95% CI 1.27-2.38], those born in Australia (AOR = 2, 95% CI 1.25-3.23), not completing Year 10 compared with those who had completed Year 12 or a higher qualification (AOR = 1.59, 95% CI 1.03-2.44), and methadone treatment (AOR = 1.61, 95% CI 1.14-2.29). The “extent” indicator was significantly and positively associated with female gender [adjusted incidence rate ratio (AIRR) = 1.56, 95% CI 1.19-2.08], unemployment (AIRR = 1.59, 95% CI 1.01-2.44), and having an injecting career of 10-20 years (AIRR = 1.76, 95% CI 1.03-3.01).
This is the peer reviewed version of the article cited above, which has been published in final form at http://doi.org/10.1111/jphd.12092. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving at http://olabout.wiley.com/WileyCDA/Section/id-820227.html#terms
Showing items related by title, author, creator and subject.
Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agentsAlzayer, R.; Hughes, Jeffery; Parsons, Richard; Lee, Ya Ping (2010)Aim The aim of this study was to examine the risk of cardiovascular diseases among users of both inhaled (ipratropium bromide or tiotropium bromide) and oral (oxybutynin and propantheline, solifenacin, tolterodine) ...
DeLisle, Brenda (2012)Background: At the end of 2009, there were 33.3 million people living globally with the Human Immunodeficiency Virus (HIV) with 2.6 million new infections occurring annually (UNAIDS, 2010). In the Commonwealth of the ...
Lun, S.; Guo, H.; Onajole, O.; Pieroni, M.; Gunosewoyo, Hendra; Chen, G.; Tipparaju, S.; Ammerman, N.; Kozikowski, A.; Bishai, W. (2013)Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge. The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium ...